PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-04-03

Date Title Company
03-Apr-2024 Nxera Pharma Appoints Experienced Senior Strategy Consultant Patrick Branch as Head of Business Development for Japan and APAC Nxera Pharma
03-Apr-2024 Agilent and UC San Diego Launch Center of Excellence in Cellular Intelligence Agilent Technologies
03-Apr-2024 Precision Oncology Innovator SimBioSys and General Inception Announce Strategic Partnership to Accelerate Cancer Drug Development SimBioSys, Inc.
03-Apr-2024 EnteroBiotix Initiates Phase 2 Study of EBX-102-02 in Patients with Irritable Bowel Syndrome (IBS) EnteroBiotix Limited
03-Apr-2024 Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio Genmab A/S
03-Apr-2024 Lindus Health Unveils Versatile “All-in-One Respiratory CRO” Offering Tailored to Respiratory Clinical Trials Lindus Health
03-Apr-2024 Astex Pharmaceuticals Announce Key Data Presentations at the American Association For Cancer Research (AACR) 2024 Annual Meeting Astex Pharmaceuticals
03-Apr-2024 ADC Therapeutics to Host a Virtual Research Investor Event on Tuesday, April 9, 2024 ADC Therapeutics
03-Apr-2024 Largest ever UK health research programme to benefit from Novartis’ multi-million pound investment Novartis
03-Apr-2024 AlzeCure presents new data regarding the TrkA-NAM pain project at IASP 2024 AlzeCure Pharma AB
03-Apr-2024 Veeva Vault CRM Now Available for All New Customers Veeva Systems
03-Apr-2024 Turbine and Harmonic Discovery Pair Simulation-Guided Biology and Multi-Target Kinase Inhibition Chemistry Expertise to Develop a Novel Cancer Therapy Harmonic Discovery
03-Apr-2024 Bespak confirms completion of inhaled and nasal drug delivery business separation from Recipharm to focus on the transition to low GWP pMDIs Bespak
03-Apr-2024 Solventum Begins Trading on the New York Stock Exchange Solventum
03-Apr-2024 CNX Therapeutics to expand CNS portfolio through the acquisition of two established brands from Eisai CNX Therapeutics Limited
03-Apr-2024 HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Endometrial Cancer with Priority Review Status HUTCHMED (China) Limited
03-Apr-2024 Clinical Collaboration Agreement Established between Teva and Launch Therapeutics to Accelerate Development of Dual-Action Asthma Rescue Inhaler (ICS-SABA/TEV-’248) Respiratory Program Teva Pharmaceutical Industries Ltd
03-Apr-2024 Reveal Lasers Reports First Quarter With Record-Breaking 300% Growth AccessWire
03-Apr-2024 Medartis launches senior convertible bond offering in a private placement of approximately CHF 115 million due 2031 Medartis Holding AG
03-Apr-2024 aap 100% approval of the proposed resolution to amend the terms and conditions of the mandatory convertible bond 2023/2028 aap Implantate AG